Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Emmanuel Favaloro and Giuseppe Lippi.
Emmanuel Favaloro
Connection Strength
43.053
Giuseppe Lippi
  1. COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check? Semin Thromb Hemost. 2022 Feb; 48(1):72-92.
    View in: PubMed
    Score: 0.951
  2. Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature. Semin Thromb Hemost. 2022 Feb; 48(1):55-71.
    View in: PubMed
    Score: 0.951
  3. Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients. Clin Chem Lab Med. 2021 10 26; 59(11):e413-e415.
    View in: PubMed
    Score: 0.951
  4. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II. Semin Thromb Hemost. 2021 06; 47(4):333-337.
    View in: PubMed
    Score: 0.948
  5. Laboratory testing for ADAMTS13: Utility for TTP diagnosis/exclusion and beyond. Am J Hematol. 2021 08 01; 96(8):1049-1055.
    View in: PubMed
    Score: 0.948
  6. The complicated relationships of heparin-induced thrombocytopenia and platelet factor 4 antibodies with COVID-19. Int J Lab Hematol. 2021 Aug; 43(4):547-558.
    View in: PubMed
    Score: 0.946
  7. Mean Platelet Volume Predicts Severe COVID-19 Illness. Semin Thromb Hemost. 2021 06; 47(4):456-459.
    View in: PubMed
    Score: 0.941
  8. Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis. Semin Thromb Hemost. 2021 Jun; 47(4):400-418.
    View in: PubMed
    Score: 0.941
  9. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part I. Semin Thromb Hemost. 2020 10; 46(7):757-762.
    View in: PubMed
    Score: 0.909
  10. D-dimer measurement in COVID-19: Silver bullet or clinical distraction? Thromb Res. 2020 12; 196:635-637.
    View in: PubMed
    Score: 0.908
  11. Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring. Semin Thromb Hemost. 2020 04; 46(3):379-382.
    View in: PubMed
    Score: 0.877
  12. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Thromb Haemost. 2020 05; 120(5):876-878.
    View in: PubMed
    Score: 0.875
  13. Statins for Preventing Venous Thrombosis: For or Against? Semin Thromb Hemost. 2019 11; 45(8):834-836.
    View in: PubMed
    Score: 0.823
  14. Recent Advances in Mainstream Hemostasis Diagnostics and Coagulation Testing. Semin Thromb Hemost. 2019 Apr; 45(3):228-246.
    View in: PubMed
    Score: 0.815
  15. Analytical Assessment of the New Roche Cobas t 711 Fully Automated Coagulation Analyzer. Semin Thromb Hemost. 2019 Apr; 45(3):308-314.
    View in: PubMed
    Score: 0.807
  16. Editorial Compilation VI. Semin Thromb Hemost. 2019 Feb; 45(1):5-9.
    View in: PubMed
    Score: 0.807
  17. Commentary: Controversies in Thrombosis and Hemostasis Part 2-Does Sticky Platelet Syndrome Exist? Semin Thromb Hemost. 2019 Feb; 45(1):69-72.
    View in: PubMed
    Score: 0.804
  18. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors. Semin Thromb Hemost. 2019 Feb; 45(1):22-35.
    View in: PubMed
    Score: 0.804
  19. Emicizumab (ACE910): Clinical background and laboratory assessment of hemophilia A. Adv Clin Chem. 2019; 88:151-167.
    View in: PubMed
    Score: 0.795
  20. Harms and Benefits of Using Aspirin for Primary Prevention of Cardiovascular Disease: A Narrative Overview. Semin Thromb Hemost. 2019 Mar; 45(2):157-163.
    View in: PubMed
    Score: 0.792
  21. On the complexity of hemostasis and the need for harmonization of test practice. Clin Chem Lab Med. 2018 09 25; 56(10):1568-1574.
    View in: PubMed
    Score: 0.787
  22. Recent initiatives in harmonization of hemostasis practice. Clin Chem Lab Med. 2018 09 25; 56(10):1608-1619.
    View in: PubMed
    Score: 0.787
  23. e-thrombosis: epidemiology, physiopathology and rationale for preventing computer-related thrombosis. Ann Transl Med. 2018 Sep; 6(17):344.
    View in: PubMed
    Score: 0.784
  24. Postanalytical considerations that may improve the diagnosis or exclusion of haemophilia and von Willebrand disease. Haemophilia. 2018 Nov; 24(6):849-861.
    View in: PubMed
    Score: 0.777
  25. Laboratory hemostasis: from biology to the bench. Clin Chem Lab Med. 2018 06 27; 56(7):1035-1045.
    View in: PubMed
    Score: 0.774
  26. Myocardial Infarction, Unstable Angina, and White Thrombi: Time to Move Forward? Semin Thromb Hemost. 2019 Feb; 45(1):115-116.
    View in: PubMed
    Score: 0.771
  27. Car Travel-Related Thrombosis: Fact or Fiction? Semin Thromb Hemost. 2018 Jun; 44(4):327-333.
    View in: PubMed
    Score: 0.768
  28. Editorial Compilation V. Semin Thromb Hemost. 2018 04; 44(3):193-196.
    View in: PubMed
    Score: 0.763
  29. Assessment of Plasma Sample Quality on Siemens Atellica COAG 360 System. Semin Thromb Hemost. 2019 04; 45(3):315-318.
    View in: PubMed
    Score: 0.750
  30. Commentary: Controversies in Thrombosis and Hemostasis Part 1-Hematidrosis: "Blood, Sweat and Fears" or A "Pigment of Fertile Imaginations?" Semin Thromb Hemost. 2018 04; 44(3):296-297.
    View in: PubMed
    Score: 0.745
  31. Venous and Arterial Thromboses: Two Sides of the Same Coin? Semin Thromb Hemost. 2018 Apr; 44(3):239-248.
    View in: PubMed
    Score: 0.735
  32. Editorial Compilation IV. Semin Thromb Hemost. 2017 09; 43(6):549-552.
    View in: PubMed
    Score: 0.731
  33. Replacing warfarin therapy with the newer direct oral anticoagulants, or simply a growth in anticoagulation therapy? Implications for pathology testing. Pathology. 2017 Oct; 49(6):639-643.
    View in: PubMed
    Score: 0.730
  34. Direct oral anticoagulants: analysis of worldwide use and popularity using Google Trends. Ann Transl Med. 2017 Aug; 5(16):322.
    View in: PubMed
    Score: 0.727
  35. Serum Concentration of Growth Differentiation Factor-15 Is Independently Associated with Global Platelet Function and Higher Fibrinogen Values in Adult Healthy Subjects. Semin Thromb Hemost. 2017 Sep; 43(6):621-628.
    View in: PubMed
    Score: 0.720
  36. Translational aspects of developmental hemostasis: infants and children are not miniature adults and even adults may be different. Ann Transl Med. 2017 May; 5(10):212.
    View in: PubMed
    Score: 0.715
  37. Impact of experimental hypercalcemia on routine haemostasis testing. PLoS One. 2017; 12(3):e0175094.
    View in: PubMed
    Score: 0.710
  38. The Intriguing Link between the Intestinal Microbiota and Cardiovascular Disease. Semin Thromb Hemost. 2017 Sep; 43(6):609-613.
    View in: PubMed
    Score: 0.708
  39. Interference of direct oral anticoagulants in haemostasis assays: high potential for diagnostic false positives and false negatives. Blood Transfus. 2017 10; 15(6):491-494.
    View in: PubMed
    Score: 0.707
  40. Exploring the iceberg of inappropriateness in hemostasis testing. Diagnosis (Berl). 2017 Mar 01; 4(1):1-2.
    View in: PubMed
    Score: 0.706
  41. Emerging treatments for hemophilia: patients and their treaters spoilt for choice, but laboratories face a difficult path? Ann Transl Med. 2017 Mar; 5(5):101.
    View in: PubMed
    Score: 0.706
  42. Editorial Compilation III. Semin Thromb Hemost. 2017 Feb; 43(1):4-7.
    View in: PubMed
    Score: 0.704
  43. Critical laboratory values in hemostasis: toward consensus. Ann Med. 2017 09; 49(6):455-461.
    View in: PubMed
    Score: 0.704
  44. Managing the patient identification crisis in healthcare and laboratory medicine. Clin Biochem. 2017 Jul; 50(10-11):562-567.
    View in: PubMed
    Score: 0.703
  45. Laboratory monitoring of direct oral anticoagulants (DOACs)-The perfect storm? Ann Transl Med. 2017 Jan; 5(1):6.
    View in: PubMed
    Score: 0.698
  46. Laboratory Monitoring or Measurement of Direct Oral Anticoagulants (DOACs): Advantages, Limitations and Future Challenges. Curr Drug Metab. 2017; 18(7):598-608.
    View in: PubMed
    Score: 0.698
  47. Preanalytical Issues in Hemostasis and Thrombosis Testing. Methods Mol Biol. 2017; 1646:29-42.
    View in: PubMed
    Score: 0.698
  48. Post-analytical Issues in Hemostasis and Thrombosis Testing. Methods Mol Biol. 2017; 1646:545-559.
    View in: PubMed
    Score: 0.698
  49. Thrombophilia testing in patients taking direct oral anticoagulants. Handle with care. Diagnosis (Berl). 2014 Dec 01; 1(4):311-312.
    View in: PubMed
    Score: 0.604
  50. Novel and emerging therapies: thrombus-targeted fibrinolysis. Semin Thromb Hemost. 2013 Feb; 39(1):48-58.
    View in: PubMed
    Score: 0.520
  51. Coagulopathies and thrombosis: usual and unusual causes and associations, Part II. Semin Thromb Hemost. 2009 Oct; 35(7):591-5.
    View in: PubMed
    Score: 0.422
  52. Coronavirus Disease 2019-Associated Coagulopathy. Mayo Clin Proc. 2021 01; 96(1):203-217.
    View in: PubMed
    Score: 0.228
  53. Statins and other drugs: Facing COVID-19 as a vascular disease. Pharmacol Res. 2020 09; 159:105033.
    View in: PubMed
    Score: 0.222
  54. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020 Aug; 507:167-173.
    View in: PubMed
    Score: 0.220
  55. Influence of hypertriglyceridemia, hyperbilirubinemia and hemolysis on thrombin generation in human plasma. Clin Chem Lab Med. 2019 Oct 25; 57(11):1784-1789.
    View in: PubMed
    Score: 0.212
  56. Drug-Induced Thrombocytopenia: Mechanisms and Laboratory Diagnostics. Semin Thromb Hemost. 2020 Apr; 46(3):264-274.
    View in: PubMed
    Score: 0.211
  57. Platelet Transfusion Thresholds: How Low Can We Go in Respect to Platelet Counting? Semin Thromb Hemost. 2020 Apr; 46(3):238-244.
    View in: PubMed
    Score: 0.211
  58. Analytical performance of the new D-dimer and antithrombin assay on Roche cobas t 711 analyzer. Int J Lab Hematol. 2019 06; 41(3):e54-e56.
    View in: PubMed
    Score: 0.200
  59. Dark chocolate modulates platelet function with a mechanism mediated by flavan-3-ol metabolites. Medicine (Baltimore). 2018 Dec; 97(49):e13432.
    View in: PubMed
    Score: 0.199
  60. Prothrombotic State Induced by Middle-Distance Endurance Exercise in Middle-Aged Athletes. Semin Thromb Hemost. 2018 Nov; 44(8):747-755.
    View in: PubMed
    Score: 0.195
  61. Sudden Cardiac and Noncardiac Death in Sports: Epidemiology, Causes, Pathogenesis, and Prevention. Semin Thromb Hemost. 2018 Nov; 44(8):780-786.
    View in: PubMed
    Score: 0.193
  62. Haemolysis index for the screening of intravascular haemolysis: a novel diagnostic opportunity? Blood Transfus. 2018 09; 16(5):433-437.
    View in: PubMed
    Score: 0.192
  63. D-Dimer Testing: Laboratory Aspects and Current Issues. Methods Mol Biol. 2017; 1646:91-104.
    View in: PubMed
    Score: 0.175
  64. Overview of Hemostasis and Thrombosis and Contribution of Laboratory Testing to Diagnosis and Management of Hemostasis and Thrombosis Disorders. Methods Mol Biol. 2017; 1646:3-27.
    View in: PubMed
    Score: 0.175
  65. Troubleshooting an isolate prolongation of activated partial thromboplastin time in a patient with acute myocardial infarction-a paradigmatic case report. Ann Transl Med. 2016 Nov; 4(21):426.
    View in: PubMed
    Score: 0.173
  66. Newer Hemostatic Agents. Semin Thromb Hemost. 2015 Oct; 41(7):802-8.
    View in: PubMed
    Score: 0.155
  67. Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study. Semin Thromb Hemost. 2021 06; 47(4):451-455.
    View in: PubMed
    Score: 0.058
  68. ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy. Int J Lab Hematol. 2021 Jul; 43 Suppl 1:129-136.
    View in: PubMed
    Score: 0.057
  69. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost. 2020 10; 46(7):859-862.
    View in: PubMed
    Score: 0.056
  70. Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost. 2020 Oct; 46(7):845-849.
    View in: PubMed
    Score: 0.056
  71. The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis. J Thromb Haemost. 2020 09; 18(9):2408-2411.
    View in: PubMed
    Score: 0.056
  72. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020 Jul; 120(7):1004-1024.
    View in: PubMed
    Score: 0.055
  73. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 06 16; 75(23):2950-2973.
    View in: PubMed
    Score: 0.055
  74. International Council for Standardization in Haematology Recommendations for Hemostasis Critical Values, Tests, and Reporting. Semin Thromb Hemost. 2020 Jun; 46(4):398-409.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.